Excise tax relief, distilled spirits used to produce hand sanitizers (COVID-19)
Excise tax relief, distilled spirits
The U.S. Treasury Department’s Alcohol and Tobacco Tax and Trade Bureau (TTB) today issued a release announcing that it will continue to waive certain excise tax provisions with regard to distilled spirits that are used in the production of hand sanitizers as a response to the coronavirus (COVID-19) pandemic.
The TTB release announces the extension of TTB hand sanitizer guidance through December 2020.
The TTB previously announced it was providing certain exemptions and waivers to distilled spirits permittees to facilitate the production of alcohol-based hand sanitizers. Read TaxNewsFlash
Subsequently, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law, providing for additional flexibility with regard to removals of distilled spirits free of tax for use in or contained in hand sanitizer that is produced and distributed in a manner consistent with Food and Drug Administration guidance related to COVID-19.
Today’s TTB release states that the agency is working to update the original guidance and to provide guidance on the additional flexibilities of the CARES Act. In the interim, TTB stated that it is extending any exemptions, waivers or other authorizations currently provided in TTB G 2020-1A, through December 31, 2020.
For more information, contact a tax professional with KPMG’s Excise Tax Practice group:
Taylor Cortright | +1 (202) 533 6188 | email@example.com
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.